These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25423710)

  • 21. Simultaneous endometrial malignant mixed mesodermal tumor and ovarian serous adenocarcinoma.
    Krigman HR; Coogan AC; Marks JR
    Arch Pathol Lab Med; 1995 Jan; 119(1):99-103. PubMed ID: 7802567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant mixed müllerian tumors of the ovary: experience with cytoreductive surgery and platinum-based combination chemotherapy.
    Mok JE; Kim YM; Jung MH; Kim KR; Kim DY; Kim JH; Kim YT; Nam JH
    Int J Gynecol Cancer; 2006; 16(1):101-5. PubMed ID: 16445618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extrauterine pelvic malignant mixed mesodermal tumors. A study of 10 cases with immunohistochemistry.
    Deligdisch L; Plaxe S; Cohen CJ
    Int J Gynecol Pathol; 1988; 7(4):361-72. PubMed ID: 2466009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platinum-based combination chemotherapy for malignant mixed mesodermal tumors of the ovary.
    Andersen WA; Young DE; Peters WA; Smith EB; Bagley CM; Taylor PT
    Gynecol Oncol; 1989 Mar; 32(3):319-22. PubMed ID: 2537779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malignant mixed mesodermal tumor presenting as metastatic lymph node adenosquamous cell carcinoma: a case report.
    Wang PH; Lai CR; Wang TD; Chao KC; Ng HT; Yu KJ
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Feb; 62(2):107-10. PubMed ID: 10063721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malignant mixed müllerian tumor of the ovary: imaging findings.
    Cho SB; Park CM; Park SW; Kim SH; Kim KA; Cha SH; Chung IJ; Kim YW; Yoon YK; Kim JS
    Eur Radiol; 2001; 11(7):1147-50. PubMed ID: 11471602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant mixed mesodermal tumours: biology and clinical aspects.
    Gourley C; Al-Nafussi A; Abdulkader M; Smyth JF; Gabra H
    Eur J Cancer; 2002 Jul; 38(11):1437-46. PubMed ID: 12110488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant mixed müllerian tumor of the ovary: report of a case and review of the literature.
    Shy SW; Lee WH; Lee MS; Lee MC
    Zhonghua Yi Xue Za Zhi (Taipei); 1993 Jun; 51(6):468-73. PubMed ID: 8281496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant mixed müllerian tumor of primary mesenteric origin associated with a synchronous ovarian cancer: case report and literature review.
    Ma CJ; Yang SF; Huang CC; Chai CY; Cheng KI; Tsai EM; Wang JY
    Eur J Gynaecol Oncol; 2008; 29(3):289-93. PubMed ID: 18592799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant mesonephric tumors of the female genital tract: a clinicopathologic study of 9 cases.
    Bagué S; Rodríguez IM; Prat J
    Am J Surg Pathol; 2004 May; 28(5):601-7. PubMed ID: 15105647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histological evaluation of mixed mesodermal tumor of the ovary.
    Ito K
    Tohoku J Exp Med; 1994 Jan; 172(1):51-7. PubMed ID: 8036621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expression of epidermal growth factor receptor, HER-2/Neu, p53, and Ki-67 antigen in uterine malignant mixed mesodermal tumors and adenosarcoma.
    Swisher EM; Gown AM; Skelly M; Ek M; Tamimi HK; Cain JM; Greer BE; Muntz HG; Goff BA
    Gynecol Oncol; 1996 Jan; 60(1):81-8. PubMed ID: 8557233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant mixed mullerian tumour of the ovary: prognostic factor and response of adjuvant platinum-based chemotherapy.
    Inthasorn P; Beale P; Dalrymple C; Carter J
    Aust N Z J Obstet Gynaecol; 2003 Feb; 43(1):61-4. PubMed ID: 12755351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytogenetic findings in four malignant mixed mesodermal tumors of the ovary.
    Pejovic T; Alm P; Iosif SC; Mitelman F; Heim S
    Cancer Genet Cytogenet; 1996 May; 88(1):53-6. PubMed ID: 8630980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen and progesterone receptors in malignant mixed mesodermal tumors of the ovary.
    Geisler JP; Wiemann MC; Miller GA; Zhou Z; Geisler HE
    J Surg Oncol; 1995 May; 59(1):45-7. PubMed ID: 7745977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant mixed müllerian tumors of the ovary: experience with surgical cytoreduction and combination chemotherapy.
    Muntz HG; Jones MA; Goff BA; Fuller AF; Nikrui N; Rice LW; Tarraza HM
    Cancer; 1995 Oct; 76(7):1209-13. PubMed ID: 8630899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mixed uterine mesodermal sarcoma in the population of southern Israel in the years 1996-1971--clinical and pathological characteristics].
    Ariad S; Rabinovitz A; Yanai-Inbar I; Piura B
    Harefuah; 1998 Jan; 134(2):93-6, 159. PubMed ID: 9517289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant mixed mullerian tumors of the ovary. An analysis of two long-term survivors.
    Dass KK; Biscotti CV; Webster K; Saxton JP
    Am J Clin Oncol; 1993 Aug; 16(4):346-9. PubMed ID: 8392289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presence of a sarcomatous component outside the ovary is an adverse prognostic factor for primary ovarian malignant mixed mesodermal/mullerian tumors: a clinicopathologic study of 47 cases.
    Kunkel J; Peng Y; Tao Y; Krigman H; Cao D
    Am J Surg Pathol; 2012 Jun; 36(6):831-7. PubMed ID: 22588065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphologic prognostic factors of malignant mixed müllerian tumors of the ovary: a clinicopathologic study of 15 cases.
    Boucher D; Têtu B
    Int J Gynecol Pathol; 1994 Jan; 13(1):22-8. PubMed ID: 8112953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.